Skip to content
MedsAcross

Medicine

Ascor 25000 mg/50 mL injection

Ascorbic acid · Intravenous · McGuff Pharmaceuticals
Available on requestPrescription onlyUS FDA Cold chain

Ascor 25000 mg/50 mL injection is a prescription medicine containing Ascorbic acid for intravenous use, marketed by McGuff Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store in a refrigerator at 2° to 8°C (36° to 46°F). Protect from light…

Key facts

Active ingredient (INN)
Ascorbic acid
Brand
Ascor
Strength
25000 mg/50 mL
Dosage form
Injection
Route
Intravenous
Packs
1 vial of 50 mL, 25 vials of 50 mL
Marketing authorisation holder
McGuff Pharmaceuticals
Manufacturer
McGuff Pharmaceuticals
Origin register
US FDA, United States
Storage
Store in a refrigerator at 2° to 8°C (36° to 46°F). Protect from light. Excursions to ambient conditions for up to 30 days during storage or shipping are acceptable.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A11GA01 Ascorbic acid
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
15 January 2018
Identifiers
RxCUI 308395, 2002739DailyMed set ID 388aad52-fc01-4784-9791-1dbc80c69306NDC 67157-101Application NDA209112

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 vial, glass in 1 carton / 50 mL in 1 vial, glass67157-101-50McGuff Pharmaceuticals15 January 2018
25 vial, glass in 1 tray / 50 mL in 1 vial, glass67157-101-51McGuff Pharmaceuticals15 January 2018

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 2 October 2017Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Ascorbic acid 25000 mg/50 mL injection.

Compare 1

Other strengths and forms of Ascorbic acid

Clinical summary

Ascorbic acid is a vitamin C indicated for the short term (up to 1 week) treatment of scurvy in adult, among other approved uses. MedsAcross supplies Ascorbic acid for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Ascorbic acid

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Ascor 25000 mg/50 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.